Eagle Pharmaceuticals News, Eagle Pharmaceuticals Quote, EGRX Quote

Eagle Pharmaceuticals (NQ:EGRX) Delayed: 4.77 +0.22 (4.84%)

Prev. Close

$4.55

Open

$4.57

52 Wk High

$102.48

52 Wk Low

$33.02

Day High

$5.01

Day Low

$4.54

P/E

N/A

EPS

$-1.02

Volume

88,216

Friends, Peers and Foes (?): GDHG, MVST, FSR, INSP, MDRX (more...)

Apr 15, 2024 07:00 AM Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcomi
Apr 12, 2024 04:17 PM Form 8-K EAGLE PHARMACEUTICALS, For: Apr 08
Apr 12, 2024 04:06 PM Eagle Pharmaceuticals (EGRX) Receives Nasdaq Non-compliance Notice
Apr 12, 2024 04:05 PM Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K
Mar 18, 2024 08:38 PM Form SC 13G/A EAGLE PHARMACEUTICALS, Filed by: Tarriff Scott
Mar 18, 2024 08:00 AM Form NT 10-K EAGLE PHARMACEUTICALS, For: Dec 31
Mar 8, 2024 04:50 PM Form 8-K EAGLE PHARMACEUTICALS, For: Mar 08
Mar 1, 2024 04:40 PM Form 4 EAGLE PHARMACEUTICALS, For: Feb 28 Filed by: Tarriff Scott
Mar 1, 2024 07:36 AM Form 8-K EAGLE PHARMACEUTICALS, For: Feb 29
Feb 29, 2024 08:24 PM Form 4 EAGLE PHARMACEUTICALS, For: Feb 27 Filed by: Cahill Brian Joseph

Entities mentioned with EGRX